Circulation, Vol 89, 635-641, Copyright © 1994 by American Heart Association
SC Cannegieter, FR Rosendaal and E Briet
BACKGROUND: Patients with mechanical heart valve prostheses may experience
valve thrombosis and subsequent systemic embolism for which they are
treated with oral anticoagulant therapy. It is essential to know reliable
estimates of the risks and benefits of this therapy in order to answer a
number of clinical questions rationally. We sought to obtain more precise
estimates of the risks and benefits by combining the data from individual
studies by using meta-analysis. METHODS AND RESULTS: We searched for
studies in which the incidences were reported of embolic or bleeding
complications in patients with mechanical heart valve prostheses. They were
collected from the Medline and Current Contents database and by
cross-references between 1970 and 1992. Since most studies vary greatly in
many respects, we used a number of inclusion criteria, thus selecting
comparable studies of acceptable quality only. The influence of
antithrombotic therapy, valve position, and valve type was analyzed by
univariate and by multivariate analysis with Poisson regression techniques.
Forty-six studies were found, including 13,088 patients studied for 53,647
patient-years. We found an incidence of major embolism in the absence of
antithrombotic therapy of 4 per 100 patient-years. With antiplatelet
therapy this risk was 2.2 per 100 patient-years, and with coumarin therapy
it was reduced to 1 per 100 patient-years. This risk varied with the type
and the site of the prosthesis. A prosthesis in mitral position increased
the risk almost twice as compared with the aortic position. Tilting disc
valves and bileaflet valves showed a lower incidence of major embolism than
caged ball valves. An incidence of major bleeding was found in patients
treated with coumarin derivatives of 1.4 per 100 patient-years. The
incidence of bleeding became significantly higher with the addition of
antiplatelet therapy, although this did not decrease the risk of
thromboembolism any further. CONCLUSIONS: These data provide a reference
for future studies and give adequate risk estimates for clinical decision
making.
ARTICLES
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
Department of Hematology, University Hospital Leiden, The Netherlands.
This article has been cited by other articles:
![]() |
T. Le Tourneau, V. Lim, J. Inamo, F. A. Miller, D. W. Mahoney, H. V. Schaff, and M. Enriquez-Sarano Achieved Anticoagulation vs Prosthesis Selection for Mitral Mechanical Valve Replacement: A Population-Based Outcome Study Chest, December 1, 2009; 136(6): 1503 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. JAFFER Perioperative management of warfarin and antiplatelet therapy Cleveland Clinic Journal of Medicine, November 1, 2009; 76(Suppl_4): S37 - S44. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schomig, N. Sarafoff, and M. Seyfarth Triple antithrombotic management after stent implantation: when and how? Heart, August 1, 2009; 95(15): 1280 - 1285. [Full Text] [PDF] |
||||
![]() |
M. Torn, S. C. Cannegieter, W. L. E. M. Bollen, F. J. M. van der Meer, E. E. van der Wall, and F. R. Rosendaal Optimal Level of Oral Anticoagulant Therapy for the Prevention of Arterial Thrombosis in Patients With Mechanical Heart Valve Prostheses, Atrial Fibrillation, or Myocardial Infarction: A Prospective Study of 4202 Patients Arch Intern Med, July 13, 2009; 169(13): 1203 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Gorard Managing anticoagulated atrial fibrillation patients undergoing endoscopy Gut, March 1, 2009; 58(3): 468 - 468. [Full Text] [PDF] |
||||
![]() |
S. Crow, R. John, A. Boyle, S. Shumway, K. Liao, M. Colvin-Adams, C. Toninato, E. Missov, M. Pritzker, C. Martin, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dal-Bianco, B. K. Khandheria, F. Mookadam, F. Gentile, and P. P. Sengupta Management of Asymptomatic Severe Aortic Stenosis J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1279 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
A M Veitch, T P Baglin, A H Gershlick, S M Harnden, R Tighe, and S Cairns Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures Gut, September 1, 2008; 57(9): 1322 - 1329. [Full Text] [PDF] |
||||
![]() |
N. Oake MSc, A. Jennings MA, A. J. Forster MD MSc, D. Fergusson PhD, S. Doucette MSc, and C. van Walraven MD MSc Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis Can. Med. Assoc. J., July 29, 2008; 179(3): 235 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Guyatt, D. J. Cook, R. Jaeschke, S. G. Pauker, and H. J. Schunemann Grades of Recommendation for Antithrombotic Agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 123S - 131S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schulman, R. J. Beyth, C. Kearon, and M. N. Levine Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 257S - 298S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H Guyatt, A. D Oxman, R. Kunz, G. E Vist, Y. Falck-Ytter, H. J Schunemann, and for the GRADE Working Group What is "quality of evidence" and why is it important to clinicians? BMJ, May 3, 2008; 336(7651): 995 - 998. [Full Text] [PDF] |
||||
![]() |
M. Skjelland, A. Michelsen, F. Brosstad, J. L. Svennevig, R. Brucher, and D. Russell Solid Cerebral Microemboli and Cerebrovascular Symptoms in Patients With Prosthetic Heart Valves Stroke, April 1, 2008; 39(4): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
N U Weir An update on cardioembolic stroke Postgrad. Med. J., March 1, 2008; 84(989): 133 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Emery, A. M. Emery, A. Knutsen, and G. V. Raikar Aortic Valve Replacement with a Mechanical Cardiac Valve Prosthesis Card. Surg. Adult, January 1, 2008; 3(2008): 841 - 856. [Full Text] |
||||
![]() |
H. V. Schaff and R. M. Suri Multiple Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1129 - 1158. [Full Text] |
||||
![]() |
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, October 16, 2007; 116(16): e391 - e413. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Herijgers and P. Verhamme Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Eur. Heart J., October 2, 2007; 28(20): 2424 - 2426. [Full Text] [PDF] |
||||
![]() |
K. Hayashida, K. Kanda, H. Yaku, J. Ando, and Y. Nakayama Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): Preparation of a prototype model J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bayliss, P. Faber, J. Dunning, and A. Ronald What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve? Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 390 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, June 1, 2007; 38(6): 2001 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nowell, E. Wilton, H. Markus, and M. Jahangiri Antithrombotic therapy following bioprosthetic aortic valve replacement Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Aguilar, R. G. Hart, C. S. Kase, W. D. Freeman, B. J. Hoeben, R. C. Garcia, J. E. Ansell, S. A. Mayer, B. Norrving, J. Rosand, et al. Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion Mayo Clin. Proc., January 1, 2007; 82(1): 82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
O. Lund and M. Bland Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marquie, G. De Geeter, D. Klug, C. Kouakam, F. Brigadeau, O. Jabourek, N. Trillot, D. Lacroix, and S. Kacet Post-operative use of heparin increases morbidity of pacemaker implantation. Europace, April 1, 2006; 8(4): 283 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Zhou, W. Zhuang, J.-G. Hu, J.-M. Li, J.-F. Yu, and L. Jiang Low-Dose Anticoagulation in Chinese Patients with Mechanical Heart Valves Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 341 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, Y. Sawa, S. Iwai, T. Kitajima, Y. Ueda, C. Coppin, H. Matsuda, and Y. Okita Fibronectin-Hepatocyte Growth Factor Enhances Reendothelialization in Tissue-Engineered Heart Valve Ann. Thorac. Surg., November 1, 2005; 80(5): 1794 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Torn, W. L. E. M. Bollen, F. J. M. van der Meer, E. E. van der Wall, and F. R. Rosendaal Risks of Oral Anticoagulant Therapy With Increasing Age Arch Intern Med, July 11, 2005; 165(13): 1527 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Eckman "Bridging On the River Kwai": The Perioperative Management of Anticoagulation Therapy Med Decis Making, July 1, 2005; 25(4): 370 - 373. [PDF] |
||||
![]() |
A. S. Dunn, J. Wisnivesky, W. Ho, C. Moore, T. McGinn, and H. S. Sacks Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis Med Decis Making, July 1, 2005; 25(4): 387 - 397. [Abstract] [PDF] |
||||
![]() |
V. J. D'Addio and G. P. Clagett Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin: Assessment of a Standardized Periprocedural Anticoagulation Regimen Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2005; 17(2): 176-1 - 177. [Abstract] [PDF] |
||||
![]() |
S. Y. Kim, N. Martin, E. C. Hsia, R. E. Pyeritz, and D. A. Albert Management of Aortic Disease in Marfan Syndrome: A Decision Analysis Arch Intern Med, April 11, 2005; 165(7): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, C. Huth, and D. Horstkotte Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement: Results of the German Experience With Low-Intensity Anticoagulation Study Chest, January 1, 2005; 127(1): 53 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Milic, Z. D. Perisic, S. S. Zivic, Z. A. Stanojkovic, A. M. Stojkovic, N. D. Karanovic, N. H. Krstic, and S. S. Salinger Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment Europace, January 1, 2005; 7(4): 374 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Kovacs, C. Kearon, M. Rodger, D.R. Anderson, A.G.G. Turpie, S.M. Bates, L. Desjardins, J. Douketis, S.R. Kahn, S. Solymoss, et al. Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin Circulation, September 21, 2004; 110(12): 1658 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Nagarajan, P. S. Lewis, P. Botha, and J. Dunning Is addition of anti-platelet therapy to warfarin beneficial to patients with prosthetic heart valves? Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 450 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 204S - 233S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Levine, G. Raskob, R. J. Beyth, C. Kearon, and S. Schulman Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 287S - 310S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Durrleman, M. Pellerin, D. Bouchard, Y. Hebert, R. Cartier, L. P. Perrault, A. Basmadjian, and M. Carrier Prosthetic valve thrombosis: Twenty-year experience at the Montreal Heart Institute J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1388 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Shah and S L Dawson Intracerebral haemorrhage, prosthetic heart valve and anticoagulation J R Soc Med, March 1, 2004; 97(3): 129 - 130. [Full Text] [PDF] |
||||
![]() |
E. Rieder, M.-T. Kasimir, G. Silberhumer, G. Seebacher, E. Wolner, P. Simon, and G. Weigel Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. G. Paez, E.J. Herrero, A. Rocha, M. Maestro, J. L. Castillo-Olivares, I. Millan, A. C. Sanmartin, and A. Cordon Resistance to Tensile Stress of a Bioadhesive Utilized for Medical Purposes: Loctite 4011 J Biomater Appl, January 1, 2004; 18(3): 179 - 192. [Abstract] [PDF] |
||||
![]() |
R. Vink, R. A. Kraaijenhagen, B. A. Hutten, R. B. A. van den Brink, B. A. de Mol, H. R. Buller, and M. Levi The optimal intensity of vitamin k antagonists in patients with mechanical heart valves: A meta-analysis J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Topol Anticoagulation With Prosthetic Cardiac Valves Arch Intern Med, October 13, 2003; 163(18): 2251 - 2252. [Full Text] [PDF] |
||||
![]() |
R. R. Moss, K. H. Humphries, M. Gao, C. R. Thompson, J. G. Abel, G. Fradet, and B. I. Munt Outcome of Mitral Valve Repair or Replacement: A Comparison by Propensity Score Analysis Circulation, September 9, 2003; 108(90101): II-90 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ionescu, N Payne, A G Fraser, J Giddings, G L Grunkemeier, and E G Butchart Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: experience from the Cardiff Embolic Risk Factor Study Heart, September 1, 2003; 89(9): 1055 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schulman Care of Patients Receiving Long-Term Anticoagulant Therapy N. Engl. J. Med., August 14, 2003; 349(7): 675 - 683. [Full Text] [PDF] |
||||
![]() |
J. E. Ansell The Perioperative Management of Warfarin Therapy Arch Intern Med, April 28, 2003; 163(8): 881 - 883. [Full Text] [PDF] |
||||
![]() |
A. S. Dunn and A. G. G. Turpie Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review Arch Intern Med, April 28, 2003; 163(8): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Christensen, N. T. Andersen, J. Attermann, V. E. Hjortdal, M. Maegaard, and J. M. Hasenkam Mechanical heart valve patients can manage oral anticoagulant therapy themselves Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 292 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text] |
||||
![]() |
H. V. Schaff and D. H. Marsh Multiple Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1017 - 1045. [Full Text] |
||||
![]() |
A. I. Schafer, M. N. Levine, B. A. Konkle, and C. Kearon Thrombotic Disorders: Diagnosis and Treatment Hematology, January 1, 2003; 2003(1): 520 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. G. Paez, E. J. Herrero, A. Rocha, M. Martin-Maestro, J. L. Castillo-Olivares, I. Millan, A. C. Sanmartin, and A. Cordon The Telescoping Suture -Part 1: Does this Technique Improve the Mechanical Behavior of a Biomaterial?: Calf Pericardium J Biomater Appl, October 1, 2002; 17(2): 85 - 103. [Abstract] [PDF] |
||||
![]() |
J. M. G. Paez, E. J. Herrero, A. Rocha, M. Martin-Maestro, J. L. Castillo-Olivares, I. Millani, A. C. Sanmartin, and A. Cordon The Telescoping Suture - Part II: A Novel Method to Improve the Mechanical Behavior of a New Biomaterial: Ostrich Pericardium J Biomater Appl, October 1, 2002; 17(2): 105 - 123. [Abstract] [PDF] |
||||
![]() |
R O M Netzer, S C Altwegg, E Zollinger, M Tauber, T Carrel, and C Seiler Infective endocarditis: determinants of long term outcome Heart, July 1, 2002; 88(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Mangi, I. F. Palacios, and D. F. Torchiana Catheter pericardiocentesis for delayed tamponade after cardiac valve operation Ann. Thorac. Surg., May 1, 2002; 73(5): 1479 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Simon-Kupilik, J. Bialy, R. Moidl, M.-T. Kasimir, M. Mittlbock, G. Seebacher, E. Wolner, and P. Simon Dilatation of the autograft root after the Ross operation Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 470 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Voller, C. Dovifat, and J. Glatz Home management of anticoagulation Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q44 - Q49. [Abstract] [PDF] |
||||
![]() |
K. Schror Combination of oral anticoagulant and platelet inhibitor drugs: focus on the pharmacological aspects of optimizing antithrombotic therapy in mechanical heart valve replacement Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q54 - Q59. [Abstract] [PDF] |
||||
![]() |
M. Perleth and R. Busse Health technology assessment of oral anticoagulation following heart valve replacement Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q60 - Q64. [Abstract] [PDF] |
||||
![]() |
J. M. G. Paez, A. Carrera, E. J. Herrero, I. Millan, A. Rocha, A. Cordon, N. Sainz, J. Mendez, and J. L. Castillo-Olivares Influence of the Selection of the Suture Material on the Mechanical Behavior of a Biomaterial to be Employed in the Construction of Implants. Part 1: Calf Pericardium J Biomater Appl, July 1, 2001; 16(1): 47 - 67. [Abstract] [PDF] |
||||
![]() |
J. M. G. Paez, A. Carrera, E. J. Herrero, I. Millan, A. Rocha, A. Cordon, N. Sainz, J. Mendez, and J. L. Castillo-Olivares Influence of the Selection of the Suture Material on the Mechanical Behavior of a Biomaterial to be Employed in the Construction of Implants. Part 2: Porcine Pericardium J Biomater Appl, July 1, 2001; 16(1): 68 - 90. [Abstract] [PDF] |
||||
![]() |
A. Notzold, M. Huppe, C. Schmidtke, P. Blomer, T. Uhlig, and H.-H. Sievers Quality of life in aortic valve replacement: pulmonary autografts versus mechanical prostheses J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1963 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Casselman, M. L. Bots, W. Van Lommel, P. J. Knaepen, R. Lensen, and F. E.E. Vermeulen Repeated thromboembolic and bleeding events after mechanical aortic valve replacement Ann. Thorac. Surg., April 1, 2001; 71(4): 1172 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Massel and S. H. Little Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis J. Am. Coll. Cardiol., February 1, 2001; 37(2): 569 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ananthasubramaniam, J. N. Beattie, H. S. Rosman, V. Jayam, and S. Borzak How Safely and for How Long Can Warfarin Therapy Be Withheld in Prosthetic Heart Valve Patients Hospitalized With a Major Hemorrhage? Chest, February 1, 2001; 119(2): 478 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hacke The Dilemma of Reinstituting Anticoagulation for Patients With Cardioembolic Sources and Intracranial Hemorrhage: How Wide Is the Strait Between Skylla and Karybdis? Arch Neurol, December 1, 2000; 57(12): 1682 - 1684. [Full Text] [PDF] |
||||
![]() |
C. Gohlke-Bärwolf VALVE DISEASE: Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery Heart, November 1, 2000; 84(5): 567 - 572. [Full Text] |
||||
![]() |
A. Stahle Homograft--the optimal aortic valve substitute? Eur. Heart J., October 2, 2000; 21(20): 1644 - 1647. [PDF] |
||||
![]() |
F. Crawley, D. Bevan, and D. Wren Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 396 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Garcia Paez, A. Carrera, A. Cordon, E. Jorge-Herrero, A. Rocha, J. Salvador, J. Mendez, J. L. Castillo-Olivares, I. Millaan, and N. Sainz Uniaxial and Biaxial Tensile Strength of Calf Pericardium Used in the Construction of Bioprostheses: Biomaterial Selection Criteria J Biomater Appl, July 1, 2000; 15(1): 47 - 64. [Abstract] [PDF] |
||||
![]() |
R. Sodian, S. P. Hoerstrup, J. S. Sperling, S. H. Daebritz, D. P. Martin, F. J. Schoen, J. P. Vacanti, and J. E. Mayer Jr Tissue engineering of heart valves: in vitro experiences Ann. Thorac. Surg., July 1, 2000; 70(1): 140 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Michaud, F. Pelosi Jr., M. D. Noble, B. P. Knight, F. Morady, and S. A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1915 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lund, S. L. Nielsen, H. Arildsen, L. B. Ilkjaer, and H. K. Pilegaard Standard aortic St. Jude valve at 18 years: performance profile and determinants of outcome Ann. Thorac. Surg., May 1, 2000; 69(5): 1459 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laffort, R. Roudaut, X. Roques, S. Lafitte, C. Deville, J. Bonnet, and E. Baudet Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis: A clinical and transesophageal echocardiographic study J. Am. Coll. Cardiol., March 1, 2000; 35(3): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Halperin, S. J. Fry, and S. L. Houser Case 37-1999 -- A 72-Year-Old Woman with a Prosthetic Aortic Valve and Intracranial Hemorrhage N. Engl. J. Med., December 9, 1999; 341(24): 1829 - 1835. [Full Text] [PDF] |
||||
![]() |
Drugs in the peri-operative period: 4 - Cardiovascular drugs DTB, December 1, 1999; 37(12): 89 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Douketis, M. A. Crowther, S. S. Cherian, and C. B. Kearon Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery Chest, November 1, 1999; 116(5): 1240 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lund, H. K. Pilegaard, L. B. Ilkjaer, S. L. Nielsen, and H. Arildsen Performance profile of the Starr-Edwards aortic cloth covered valve, track valve, and silastic ball valve Eur. J. Cardiothorac. Surg., October 1, 1999; 16(4): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gorter Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors Neurology, October 1, 1999; 53(6): 1319 - 1319. [Abstract] [Full Text] |
||||
![]() |
S. Torregrosa, J. Gomez-Plana, F. J. Valera, J. Caffarena, J. M. Maronas, F. Garcia-Sanchez, J. Peris, R. Frias, and J. M. Caffarena Long-term clinical experience with the omnicarbon prosthetic valve Ann. Thorac. Surg., September 1, 1999; 68(3): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bader, T. Schilling, O. E. Teebken, G. Brandes, T. Herden, G. Steinhoff, and A. Haverich Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves Eur. J. Cardiothorac. Surg., September 1, 1999; 14(3): 279 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. North, L. Sadler, A. W. Stewart, L. M.E. McCowan, A. R. Kerr, and H. D. White Long-Term Survival and Valve-Related Complications in Young Women With Cardiac Valve Replacements Circulation, May 25, 1999; 99(20): 2669 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. G. Paez and E. Jorge-Herrero Assessment of Pericardium in Cardiac Bioprostheses: A Review J Biomater Appl, April 1, 1999; 13(4): 351 - 388. [Abstract] [PDF] |
||||
![]() |
J. Barbetseas, S. F. Nagueh, C. Pitsavos, P. K. Toutouzas, M. A. Quinones, and W. A. Zoghbi Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1410 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Hoerstrup, G. Zund, A. Schoeberlein, Q. Ye, P. R. Vogt, and M. I. Turina Fluorescence activated cell sorting: A reliable method in tissue engineering of a bioprosthetic heart valve Ann. Thorac. Surg., November 1, 1998; 66(5): 1653 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Podesser, G. Khuenl-Brady, E. Eigenbauer, S. Roedler, A. Schmiedberger, E. Wolner, and A. Moritz Long-term results of heart valve replacement with the Edwards Duromedics bileaflet prosthesis: A prospective ten-year clinical follow-up J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1121 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Altman Controversies in Antithrombotic Therapy in Cardiovascular Diseases Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 11 - 24. [Abstract] [PDF] |
||||
![]() |
J.-H. Jansson, K. Boman, M. Brannstrom, and T. K. Nilsson High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment Circulation, November 4, 1997; 96(9): 2938 - 2943. [Abstract] [Full Text] |
||||
![]() |
C. Kearon and J. Hirsh Management of Anticoagulation before and after Elective Surgery N. Engl. J. Med., May 22, 1997; 336(21): 1506 - 1511. [Full Text] [PDF] |
||||
![]() |
S. S. Meschengieser, C. G. Fondevila, J. Frontroth, M. T. Santarelli, and M. A. Lazzari LOW-INTENSITY ORAL ANTICOAGULATION PLUS LOW-DOSE ASPIRIN VERSUS HIGH-INTENSITY ORAL ANTICOAGULATION ALONE: A RANDOMIZED TRIAL IN PATIENTS WITH MECHANICAL PROSTHETIC HEART VALVES J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 910 - 916. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |